Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06296485 · ClinicalTrials.gov registry record · NA

Safer Aging With Diabetes Monitoring

A NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, sponsored by Kaiser Permanente.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
4
Study locations

NCT06296485: Recruiting NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, sponsored by Kaiser Permanente.

NCT06296485 is a NA study of Diabetes Mellitus, Type 2 and Hypoglycemia that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 360 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06296485, a NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
4
Study locations

Study Summary

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Primary Outcome

This outcome will compare the proportion of patients in the three study arms with self-reported hypoglycemia (symptomatic and/or requiring help from others) and/or hypoglycemia-related utilization (emergency department, hospital or outpatient new events) 6- and 12-months after enrollment

Interventions

  • OTHER Usual Care
  • BEHAVIORAL SAGE Group Sessions

Study Locations (4)

California

  • Kaiser Permanente Fremont - Fremont
  • Kaiser Permanente San Jose - San Jose
  • Kaiser Permanente San Leandro - San Leandro
  • Kaiser Permanente - Union City - Union City

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2024-05-01
Est. Completion 2028-01-31
Phase NA
Kaiser Permanente

294 total trials

What NCT06296485 shows while recruiting

NCT06296485 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT06296485 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06296485 about?

NCT06296485 is a clinical study titled "Safer Aging With Diabetes Monitoring". Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational progra...

What is the current status of trial NCT06296485?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2024-05-01. Estimated completion is 2028-01-31.

What conditions does trial NCT06296485 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Hypoglycemia.

What interventions are being tested in trial NCT06296485?

The interventions under investigation include: Usual Care (OTHER), SAGE Group Sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06296485?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06296485 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06296485's enrollment target sits among peer trials

360 100th of 348 higher than 248 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747836 · 360 participants

    Ultrasound Analysis of Human Carpal Tunnel System

  • NCT04089046 · 360 participants · NA

    Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)

  • NCT04130503 · 360 participants · NA

    The Recovery in Stroke Using PAP Study

  • NCT04160000 · 360 participants · Phase 4

    Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06296485, the US trial registry maintained by the National Library of Medicine. NCT06296485 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.